EU seals deal with Pfizer-BioNTech for 300M doses of COVID vaccine

The 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.

The European Commission said on Wednesday it had sealed a deal with Pfizer and BioNTech for the supply of up to 300 million doses of their COVID-19 vaccine candidate.

COVID-19 VACCINE BY THE NUMBERS

The move follows Pfizer's announcement on Monday that its experimental vaccine developed with BioNTech was more than 90% effective, making them the first drugmakers to show successful interim data from a large-scale clinical trial of a coronavirus vaccine.

Ticker Security Last Change Change %
PFE PFIZER INC. 25.82 -0.39 -1.49%
BNTX BIONTECH SE 117.20 -1.19 -1.01%

Under the EU deal, the 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

The EU has already signed supply deals with AstraZeneca, Sanofi and Johnson & Johnson for their experimental COVID-19 shots, and is talking with Moderna, CureVac and Novavax to secure their vaccines.